MDXG
MIMEDX GROUP, INC.Company Information
- Company Name
- MIMEDX GROUP, INC.
- CIK
- CIK0001376339
- Category
- Large accelerated filer
- Ticker: Exchange
- MDXG: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- MDXG
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-05-02
- Last sale
- 2025-11-06
- Shares purchased (TTM)
- 200,000
- Shares sold (TTM)
- 263,738
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 111,228,330
- Shares outstanding
- 147,795,741
- Ownership
- 75.26%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | - | 81 | ||||||
| Cash And Cash Equivalents At Carrying Value | 136 | 160 | 166 | 142 | 119 | 106 | 104 | 89 | 69 | 48 | 82 | - | ||||||
| Accounts Receivable Net Current | 41 | 46 | 76 | 78 | 69 | 62 | 56 | 54 | 53 | 57 | 54 | 49 | ||||||
| Inventory Net | 21 | 26 | 25 | 27 | 25 | 24 | 24 | 24 | 25 | 24 | 21 | 19 | ||||||
| Prepaid Expense Current | - | - | - | 4 | 5 | 5 | 5 | 3 | 4 | 6 | 6 | 3 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Other Assets Current | 7 | 8 | 10 | 3 | 3 | 2 | 8 | 2 | 3 | 3 | 2 | 2 | ||||||
| Assets Current | 205 | 240 | 277 | 254 | 221 | 200 | 192 | 172 | 154 | 139 | 164 | 155 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | ||||||
| Deferred Income Tax Assets Net | 27 | 24 | 20 | 22 | 27 | 28 | 28 | 31 | 33 | 39 | 41 | - | ||||||
| Operating Lease Right Of Use Asset | - | - | 4 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | ||||||
| Goodwill | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | ||||||
| Intangible Assets Net Excluding Goodwill | 12 | 13 | 14 | 11 | 12 | 11 | 12 | 11 | 12 | 13 | 5 | 5 | ||||||
| Other Assets Noncurrent | 12 | 7 | 7 | 3 | 1 | 1 | 7 | 1 | 1 | 1 | 0 | 0 | ||||||
| Assets | 281 | 309 | 343 | 319 | 291 | 270 | 264 | 244 | 230 | 222 | 239 | 189 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Long Term Debt Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Accounts Payable Current | 8 | 11 | 15 | 11 | 8 | 9 | 7 | 7 | 8 | 10 | 9 | 9 | ||||||
| Employee Related Liabilities Current | 13 | 15 | 31 | 28 | 22 | 19 | 24 | 20 | 18 | 18 | 22 | 23 | ||||||
| Accrued Liabilities Current | 11 | 11 | 11 | 13 | 15 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | ||||||
| Other Liabilities Current | 4 | 6 | 6 | 4 | 3 | 4 | 5 | 3 | 2 | 4 | 3 | 2 | ||||||
| Liabilities Current | 38 | 45 | 64 | 58 | 50 | 43 | 46 | 42 | 40 | 42 | 46 | 44 | ||||||
| Long Term Debt Noncurrent | 16 | 16 | 16 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 48 | 49 | ||||||
| Business Combination Contingent Consideration Liability Current | - | - | - | - | - | - | 1 | 3 | 2 | - | 0 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | - | ||||||
| Other Liabilities Noncurrent | 11 | 5 | 5 | 6 | 7 | 7 | 7 | 3 | 4 | 5 | 2 | 3 | ||||||
| Liabilities | 65 | 66 | 86 | 80 | 74 | 68 | 71 | 63 | 62 | 66 | 96 | 95 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | - | 0 | 92 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 297 | 296 | 299 | 297 | 291 | 287 | 284 | 280 | 275 | 280 | 276 | 188 | ||||||
| Treasury Stock Value | -13 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -68 | -54 | -43 | -58 | -75 | -84 | -91 | -99 | -107 | -124 | -134 | -187 | ||||||
| Stockholders Equity | 216 | 243 | 257 | 239 | 217 | 203 | 193 | 181 | 168 | 156 | 143 | 1 | ||||||
| Liabilities And Stockholders Equity | 281 | 309 | 343 | 319 | 291 | 270 | 264 | 244 | 230 | 222 | 239 | 189 | ||||||
| Shares Outstanding | 146 | 149 | 148 | 148 | 148 | 148 | 147 | 147 | 147 | 148 | 146 | 116 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | - | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | - | 5 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 149 | 149 | 148 | 148 | 148 | 148 | 147 | 147 | 147 | 148 | 146 | 116 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Treasury Stock Common Shares | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMIMEDX GROUP, INC. (MDXG) — SEC Financial Statements & Analysis
MIMEDX GROUP, INC. (MDXG) is a surgical & medical instruments & apparatus company. MIMEDX GROUP, INC. trades on Nasdaq as: MDXG. MIMEDX GROUP, INC. (MDXG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, MIMEDX GROUP, INC. carries a market cap of $569.01M, a P/E ratio of 91.23x, a P/B ratio of 2.63x, a P/S ratio of 1.60x, an enterprise value of $450.38M, and an EV/EBITDA multiple of 47.00x. On profitability, it posts a gross margin of 78.85%, an operating margin of 2.46%, a net margin of 1.76%, a Return on Equity (ROE) of 2.88%, a Return on Assets (ROA) of 2.18%, and a Return on Invested Capital (ROIC) of 4.15%. Per share, it reports EPS of $0.04, diluted EPS of $0.04, free cash flow per share of $0.31, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.36% year-over-year, net income growth of -80.61% year-over-year, and EPS growth of -80.62% year-over-year. On the balance sheet, it maintains a current ratio of 5.33x, a quick ratio of 4.79x, working capital of $166.87M, a debt-to-equity ratio of 0.30x, a debt ratio of 0.23, an interest coverage ratio of 2.60x, free cash flow of $46.15M (TTM), and net debt of $-118.63M. Figures sourced from SEC EDGAR.
- Market Cap
- $569.01M
- P/E TTM
- 91.23x
- EPS TTM
- $0.04
- P/B TTM
- 2.63x
- ROE TTM
- 2.88%
- ROA TTM
- 2.18%
- Debt To Equity
- 0.30x
- Free Cash Flow TTM
- $46.15M
- Net Revenue TTM Growth 1Y
- -2.36%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MIMEDX GROUP, INC. in?
MIMEDX GROUP, INC. (MDXG) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does MDXG trade on?
MIMEDX GROUP, INC. (MDXG) trades on the Nasdaq.
When was MIMEDX GROUP, INC. (MDXG)'s most recent SEC filing?
MIMEDX GROUP, INC. (MDXG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is MDXG's market cap?
MIMEDX GROUP, INC. (MDXG) has a market capitalization of $569.01M as of 2026-06-30.
What is MDXG's P/E ratio?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month P/E ratio is 91.23x as of 2026-06-30.
What is MDXG's EPS (earnings per share)?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month EPS is $0.04 as of 2026-06-30.
What is MDXG's ROE (return on equity)?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month Return on Equity (ROE) is 2.88% as of 2026-06-30.
What is MDXG's ROA (return on assets)?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month Return on Assets (ROA) is 2.18% as of 2026-06-30.
What is MDXG's ROIC (return on invested capital)?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month Return on Invested Capital (ROIC) is 4.15% as of 2026-06-30.
What is MDXG's EV/EBITDA?
MIMEDX GROUP, INC. (MDXG)'s trailing twelve month EV/EBITDA is 47.00x as of 2026-06-30.